Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Utilization Patterns of Aflibercept 8 mg in Japan: a Retrospective Descriptive Study Using the Claims Database

NCT06929143 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT06929143
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06929143 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Utilization Patterns of Aflibercept 8 mg in Japan: a Retrospective Descriptive Study Using the Claims Database
Lead sponsor
Bayer
Phase
Observational
Overall status
Active, not recruiting
Start date
April 14, 2025
Completion date
July 30, 2027
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema (dme), neovascular age-related macular degeneration (namd)